Best Factor Xa Inhibitor for pulmonary embolism
Top-rated pick: Xarelto — pharmaranks score 70/100, the highest of the 3 Factor Xa Inhibitor drugs used for pulmonary embolism, ranked by our independent FDA recall-safety score. Compare them with all treatments for pulmonary embolism or the full Factor Xa Inhibitor class. Not medical advice — always consult a professional.
Quick answer: Of the 3 factor xa inhibitor drugs we rate for pulmonary embolism, 1 is available as lower-cost generics, and most are suspension. Our ranking reflects each drug’s FDA recall-safety record — not clinical effectiveness for pulmonary embolism; the right choice depends on your situation, so confirm it with your prescriber.
Other drug classes for pulmonary embolism
Top factor xa inhibitor for pulmonary embolism: 1. Xarelto · 2. Eliquis · 3. Eliquis Sprinkle
| # | Drug | Rating | Type | Form | Generic? | Pharmacy pays | |
|---|---|---|---|---|---|---|---|
| 1 | 70/100 | Prescription | Suspension | Generic | $1 | View → | |
| 2 | Not yet rated | Prescription | Tablet | No data | — | View → | |
| 3 | Not yet rated | Prescription | Capsule | No data | — | View → |
Full ranking · 3 drugs
xarelto
Boxed warningPrescriptionFDA-sourced
Xarelto (Rivaroxaban) is a factor xa inhibitor used to treat Pulmonary Embolism, Venous Thrombosis.
Pharmacy pays
From ~$0.96· 2 formseliquis
PrescriptionFDA-sourced
Eliquis (Apixaban) is a factor xa inhibitor used to treat Pulmonary Embolism, Venous Thrombosis.
Price varies
eliquis sprinkle
PrescriptionFDA-sourced
Eliquis Sprinkle (Apixaban) is a factor xa inhibitor used to treat Pulmonary Embolism, Venous Thrombosis.
Price varies
Frequently asked
- What is the best factor xa inhibitor for pulmonary embolism?
- By our independent recall-safety rating — not an efficacy measure — xarelto ranks highest among Factor Xa Inhibitor drugs used for pulmonary embolism. Always consult a professional.
- Which factor xa inhibitor drugs treat pulmonary embolism?
- pharmaranks lists 3 Factor Xa Inhibitor products used for pulmonary embolism, per NIH RxClass drug-classification data — each independently rated and ranked above.
- How are these ranked?
- By our independent score, currently based on FDA regulatory recall-safety data (the methodology blends additional sources as they come online). See the How we rate page.